ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.71M | -15.31M | -15.03M | -14.48M | -14.00M |
| Total Depreciation and Amortization | 345.50K | 372.50K | 422.00K | 753.90K | 1.08M |
| Total Amortization of Deferred Charges | 2.53M | 2.53M | 2.53M | 1.80M | 1.10M |
| Total Other Non-Cash Items | 1.39M | 1.23M | 1.07M | 28.60K | -1.01M |
| Change in Net Operating Assets | 1.20M | 1.20M | 1.20M | 815.60K | 445.70K |
| Cash from Operations | -10.25M | -9.99M | -9.81M | -11.08M | -12.39M |
| Capital Expenditure | -38.00K | -38.00K | -38.00K | -18.80K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -222.90K | -249.60K | -277.10K | -641.00K | -1.01M |
| Cash from Investing | -260.90K | -287.60K | -315.10K | -659.80K | -1.01M |
| Total Debt Issued | 23.64M | 19.81M | 15.97M | 7.98M | -- |
| Total Debt Repaid | -373.00K | -397.50K | -422.00K | -442.00K | -462.00K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.35M | -2.63M | -1.90M | -951.50K | 0.00 |
| Cash from Financing | 12.76M | 10.70M | 8.64M | 4.12M | -304.70K |
| Foreign Exchange rate Adjustments | -1.58M | -925.70K | -258.80K | 392.30K | 1.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 660.30K | -505.70K | -1.74M | -7.22M | -12.66M |